{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:50:02Z","timestamp":1784631002929,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bmc.2024.117833","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:53:08Z","timestamp":1720540388000},"page":"117833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting prolidase. A survey of the literature data to depict a structure-activity relationship frame and to address future studies for drug development"],"prefix":"10.1016","volume":"110","author":[{"given":"Serena","family":"Fiorito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Collevecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Epifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117833_b0005","article-title":"Prolidase: a review from its discovery to its role in health and disease","volume":"31","author":"Eni-Aganga","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.bmc.2024.117833_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.biochi.2020.09.017","article-title":"Prolidase: a protein with many faces","volume":"183","author":"Wilk","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.bmc.2024.117833_b0015","first-page":"108","article-title":"Clinical genetics of prolidase deficiency. An updated review","volume":"9","author":"Spodenkiewicz","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bmc.2024.117833_b0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2613.2000.00168.x","article-title":"Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale","volume":"81","author":"Karna","year":"2000","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.bmc.2024.117833_b0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2613.2006.00486.x","article-title":"Enhanced prolidase activity and decreased collagen content in breast cancer tissue","volume":"87","author":"Cechowska-Pasko","year":"2006","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.bmc.2024.117833_b0030","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s11095-007-9249-9","article-title":"Proline prodrug of melphalan targeted to prolidase. A prodrug activating enzyme overexpressed in melanoma","volume":"24","author":"Mittal","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.bmc.2024.117833_b0035","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/IGC.0b013e3181af711e","article-title":"Serum prolidase activity and oxidative status in patients with stage I endometrial cancer","volume":"19","author":"Arioz","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bmc.2024.117833_b0040","article-title":"Evaluation of antioxidant enzyme levels, oxidative stress markers and serum prolidase activity in testicular cancer","volume":"14","author":"Kaba","year":"2024","journal-title":"Urologia"},{"key":"10.1016\/j.bmc.2024.117833_b0045","doi-asserted-by":"crossref","first-page":"116.e9","DOI":"10.1016\/j.urolonc.2024.01.007","article-title":"Serum prolidase activity, oxidative stress, and antioxidant enzyme levels in patients with prostate cancer","volume":"42","author":"Kaba","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.bmc.2024.117833_b0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3390\/cancers16020456","article-title":"Proline metabolism in WHO G4 gliomas is altered as compared to unaffected brain tissue","volume":"16","author":"Sawicka","year":"2024","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.bmc.2024.117833_b0055","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3390\/cancers14082030","article-title":"Proline metabolism in malignant gliomas: a systematic literature review","volume":"14","author":"Sawicka","year":"2023","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.bmc.2024.117833_b0060","article-title":"Human specific proline peptidases: a comprehensive review analysis","volume":"1864","author":"Dunaevsky","year":"2020","journal-title":"BBA"},{"key":"10.1016\/j.bmc.2024.117833_b0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000536117","article-title":"Chronic liver disease in patients with prolidase deficiency: a case series","volume":"18","author":"Gopalakrishna","year":"2024","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.bmc.2024.117833_b0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1203\/PDR.0b013e3180676d05","article-title":"Prolidase isoenzymes in the rat: their organ distribution, developmental change and specific inhibitors","volume":"62","author":"Liu","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.bmc.2024.117833_b0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1432-1033.1989.tb14659.x","article-title":"Inhibition and active site modelling of prolidase","volume":"180","author":"King","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bmc.2024.117833_b0080","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00249-009-0459-4","article-title":"Identifying the structure of the active sites of human recombinant prolidase","volume":"39","author":"Besio","year":"2010","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.bmc.2024.117833_b0085","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1111\/febs.14158","article-title":"Substrate specificity and reaction mechanism of human prolidase","volume":"284","author":"Wilk","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.bmc.2024.117833_b0090","article-title":"RCSB PDB - 2IW2: Crystal Structure of Human Prolidase","author":"Mueller","year":"2006","journal-title":"Homo Sapiens"},{"key":"10.1016\/j.bmc.2024.117833_b0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0014-827X(00)00095-1","article-title":"Cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells","volume":"55","author":"Bielawska","year":"2000","journal-title":"Farmaco"},{"key":"10.1016\/j.bmc.2024.117833_b0100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0014-827X(01)01130-2","article-title":"Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts","volume":"56","author":"Chrzanowski","year":"2001","journal-title":"Farmaco"},{"key":"10.1016\/j.bmc.2024.117833_b0105","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/cmdc.200700229","article-title":"Small molecules based delivery system for alkylating neoplastic compounds","volume":"3","author":"Bielawski","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2024.117833_b0110","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0014-827X(03)00164-2","article-title":"Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells","volume":"58","author":"Chrzanowski","year":"2003","journal-title":"Farmaco"},{"key":"10.1016\/j.bmc.2024.117833_b0115","first-page":"679","article-title":"Acetylsalicylic acid as a potential regulator of prolidase-convertible pro-drugs in control and neoplastic cells","volume":"58","author":"Chrzanowski","year":"2003","journal-title":"Farmaco"},{"key":"10.1016\/j.bmc.2024.117833_b0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/mp049922p","article-title":"Prolidase, a potential enzyme target for melanoma: design of proline containing dipeptide-like prodrugs","volume":"2","author":"Mittal","year":"2004","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2024.117833_b0125","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s11095-007-9249-9","article-title":"Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma","volume":"24","author":"Mittal","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.bmc.2024.117833_b0130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ejpb.2007.03.024","article-title":"Proline prodrug of melphalan, prophalan-L, demonstrates high therapeutic index in a murine melanoma model","volume":"67","author":"Mittal","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.bmc.2024.117833_b0135","first-page":"171","article-title":"Proline-linked nitrosoureas as prolidase-convertible prodrugs in human breast cancer cells","volume":"60","author":"Bielawski","year":"2008","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bmc.2024.117833_b0140","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1016\/j.bmcl.2010.07.024","article-title":"Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells","volume":"20","author":"Wu","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117833_b0145","first-page":"157","article-title":"N-benzyloxycarbonyl-l-proline: An in vitro and in vivoinhibitor of prolidase","volume":"1744","author":"Lupi","year":"2005","journal-title":"BBA"},{"key":"10.1016\/j.bmc.2024.117833_b0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cccn.2004.08.006","article-title":"Effects of amino acids and its metabolites on prolidase activityagainst various iminodipeptides in erythrocytes from normalhuman and a patient with prolidase deficiency","volume":"350","author":"Liu","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bmc.2024.117833_b0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0940-2993(00)80108-6","article-title":"The mechanism of daunorubicin-induced inhibition of prolidase activity in human skin fibroblasts and its implication to impaired collagen biosynthesis","volume":"52","author":"Muszy\u0144ska","year":"2000","journal-title":"Exp Toxic Pathol"},{"key":"10.1016\/j.bmc.2024.117833_b0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(01)01372-3","article-title":"Doxycycline-induced inhibition of prolidase activity in human skinfibroblasts and its involvement in impaired collagen biosynthesis","volume":"430","author":"Karna","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2024.117833_b0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(00)00847-5","article-title":"The mechanism for anthracycline-induced inhibition of collagen biosynthesis","volume":"411","author":"Muszy\u0144ska","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2024.117833_b0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-2999(02)01793-4","article-title":"Melanin potentiates gentamicin-induced inhibition of collagen biosynthesis in human skin fibroblasts","volume":"446","author":"Wrze\u015bniok","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2024.117833_b0175","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1016\/j.bmc.2006.09.027","article-title":"Effect of melanin on netilmicin-induced inhibition of collagen biosynthesis in human skin fibroblasts","volume":"14","author":"Buszman","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117833_b0180","first-page":"BR175-179","article-title":"Acetylsalicylic acid-dependent inhibition of collagen biosynthesis and \u03b21-integrin signaling in cultured fibroblasts","volume":"10","author":"Sura\u017cy\u0144ski","year":"2004","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.bmc.2024.117833_b0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1010849100540","article-title":"Phosphorylation of prolidase increases the enzyme activity","volume":"220","author":"Sura\u017cy\u0144ski","year":"2001","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bmc.2024.117833_b0190","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.etap.2005.06.003","article-title":"Acetylsalicylic acid prevents nickel-induced collagenbiosynthesis in human fibroblasts","volume":"20","author":"Miltyk","year":"2005","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.bmc.2024.117833_b0195","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1002\/elps.200600197","article-title":"Kinetic study of paracetamol on prolidase activity in erythrocytes by capillary electrophoresis with Ru(bpy)32+ electrochemiluminescence detection","volume":"27","author":"Yuan","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bmc.2024.117833_b0200","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0006-2952(85)90507-6","article-title":"Inhibition of rat and human prolidase by capropril","volume":"34","author":"Ganapathy","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2024.117833_b0205","first-page":"614","article-title":"Captopril-dependent inhibition of collagen biosynthesis in cultured fibroblasts","volume":"65","author":"Karna","year":"2010","journal-title":"Pharmazie"},{"key":"10.1016\/j.bmc.2024.117833_b0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2164\/jandrol.109.008631","article-title":"The association of serum prolidase activity and erectile dysfunction","volume":"31","author":"Savas","year":"2010","journal-title":"J Androl"},{"key":"10.1016\/j.bmc.2024.117833_b0215","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1590\/S1807-59322010001200014","article-title":"Acute effect of phosphodiesterase type 5 inhibitoron serum oxidative status and prolidase activities inmen with erectile dysfunction","volume":"65","author":"Savas","year":"2010","journal-title":"Clinics"},{"key":"10.1016\/j.bmc.2024.117833_b0220","first-page":"1923","article-title":"Influence of caffeine and hyaluronic acid on collagen biosynthesis in human skin fibroblasts","volume":"8","author":"Donejko","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmc.2024.117833_b0225","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/ptr.5143","article-title":"The influence of selected flavonoids from the leaves of Cirsium palustre (L.) Scop. On collagen expression in human skin fibroblasts","volume":"28","author":"Nazaruk","year":"2014","journal-title":"Phytother Res"},{"key":"10.1016\/j.bmc.2024.117833_b0230","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/14786419.2015.1038535","article-title":"Prolidase-dependent mechanism of (Z)-8,9-epoxyheptadeca-1,11,14-triene-induced inhibition of collagen biosynthesis in cultured human skin fibroblasts","volume":"30","author":"Szoka","year":"2016","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmc.2024.117833_b0235","doi-asserted-by":"crossref","first-page":"e23206","DOI":"10.1002\/jbt.23206","article-title":"Betulinic acid: A natural promising anticancer drug, current situation, and future perspectives","volume":"36","author":"Aswathy","year":"2022","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.bmc.2024.117833_b0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11010-010-0395-8","article-title":"Betulinic acid inhibits the expression of hypoxia-inducible factor 1a and vascular endothelial growth factor in human endometrial adenocarcinoma cells","volume":"340","author":"Karna","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bmc.2024.117833_b0245","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1248\/bpb1978.5.734","article-title":"An inhibitor for post proline cleaving enzyme: distribution and partial purification from porcine pancreas","volume":"5","author":"Yoshimoto","year":"1982","journal-title":"J Pharm Dyn"},{"key":"10.1016\/j.bmc.2024.117833_b0250","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/DER.0000000000000428","article-title":"Paraben toxicology","volume":"30","author":"Fransway","year":"2019","journal-title":"Dermatitis"},{"key":"10.1016\/j.bmc.2024.117833_b0255","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/jat.3466","article-title":"Methylparaben-induced decrease in collagen production and viability of cultured human dermal fibroblasts","volume":"37","author":"Majewska","year":"2017","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.bmc.2024.117833_b0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cca.2006.06.027","article-title":"Different effects of sulfur amino acids on prolidase and prolinase activity in normal and prolidase-deficient human erythrocytes","volume":"375","author":"Uramatsu","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bmc.2024.117833_b0265","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00210-015-1114-5","article-title":"Enalapril stimulates collagen biosynthesis through prolidase-dependent mechanism in cultured fibroblasts","volume":"388","author":"Szoka","year":"2015","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bmc.2024.117833_b0270","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.biopha.2017.08.104","article-title":"Acetylenic derivative of betulin induces apoptosis in endometrial adenocarcinoma cell line","volume":"95","author":"Szoka","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2024.117833_b0275","first-page":"889","article-title":"Stimulation of collagen biosynthesis by flavonoid glycosides in skin fibroblasts of osteogenesis imperfecta type I and the potential mechanism of their action","volume":"20","author":"Galicka","year":"2007","journal-title":"Int J Mol Med"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624002475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624002475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T04:09:40Z","timestamp":1722053380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624002475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":55,"alternative-id":["S0968089624002475"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117833","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting prolidase. A survey of the literature data to depict a structure-activity relationship frame and to address future studies for drug development","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117833"}}